In global equity trading, ARCT is the official ticker symbol for Arcturus Therapeutics Holdings Inc., a clinical-stage messenger RNA medicines and vaccines company listed on the Nasdaq exchange. The enterprise focuses on discovering, developing, and commercializing infectious disease vaccines and significant liver and respiratory rare disease therapeutics utilizing advanced lipid nanoparticle delivery technologies.